Ignite Creation Date:
2024-05-05 @ 11:34 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00089245
Status:
TERMINATED
Last Update Posted:
2023-12-26
First Post:
2004-08-04
Brief Title:
Radiolabeled MAB Therapy in Patients With Refractory Recurrent or Advanced CNS or Leptomeningeal Cancer
Sponsor:
Y-mAbs Therapeutics
Organization:
Y-mAbs Therapeutics
Organization Data
Organization:
Y-mAbs Therapeutics
Class:
INDUSTRY
Study ID:
03-133
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Y-mAbs Therapeutics
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Memorial Sloan Kettering Cancer Center | OTHER |